Redhawk Wealth Advisors, Inc. Exelixis, Inc. Transaction History

Redhawk Wealth Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 04, 2019	SELL	$17.68 - $22.65 $176,004 - $225,480	-9,955 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$13.65 - $21.8 $158,271 - $252,771	-11,595 Reduced 53.81%	9,955 $209,000
Q3 2018 Nov 15, 2018	BUY	$15.87 - $22.4 $341,998 - $482,719	21,550 New	21,550 $382,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Redhawk Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Redhawk Wealth Advisors, Inc. with notifications on news.